Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma 2021-08-02 07:29
Rey Announces $10 Million in New Series A Funding to Expand Access to Mental Health through Digital Capabilities 2021-07-31 02:56
Appendix 4C - Q4 FY21 Quarterly Cash Flow Report 2021-07-30 21:05
China Jo-Jo Drugstores Completes Redomiciliation Merger 2021-07-30 21:00
I-Mab Announces IND Approval by FDA to Initiate Phase 1 Study for Protollin for the Treatment of Alzheimer's Disease 2021-07-30 20:00
EC Healthcare and Prenetics Form Strategic Partnership to Pioneer the Future of Medicine 2021-07-30 15:33
Joint Commission of Taiwan shares Taiwan's experience in smart healthcare 2021-07-30 15:30
CliniRx Becomes a Medidata Rave EDC Accredited Partner 2021-07-30 13:00
Neukio Biotherapeutics completed its $40m Angel round financing, focusing on the development of iPSC-CAR-NK platform and assets. 2021-07-30 08:00
Global Cord Blood Corporation Files Annual Report on Form 20-F 2021-07-30 04:16
Highlights From The Alzheimer's Association International Conference 2021 2021-07-30 03:44
COVID-19 Associated With Long-Term Cognitive Dysfunction, Acceleration Of Alzheimer's Symptoms 2021-07-30 03:00
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI 2021-07-29 21:30
EDM Council Report Uncovers Major Evolution in Data Management Practices within Pharma / Life Sciences 2021-07-29 21:10
I-Mab Announces Authorization of a Renewed Stock Repurchase Program by the Company up to US$40 Million 2021-07-29 20:00
HanAll Biopharma Reports Second Quarter 2021 Results 2021-07-29 18:44
Everest Medicines Receives Pediatric and Rare Severe Disease Priority Review Designation from Taiwan FDA for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer 2021-07-29 18:41
Daewoong Pharmaceutical Announces Camostat Achieving 50% Faster Recovery Time for Mild COVID-19 Patients Over Age of 50 in Topline Results from Phase 2B Clinical Trial 2021-07-29 18:00
Exyte Empowers the Biopharmaceutical Industry: First ExyCell(R) Facility Launched in Shanghai 2021-07-29 16:25
Transcenta Announces Orphan Drug Designation Granted to TST001 for Treatment of Gastric and Gastroesophageal Junction 2021-07-29 07:46
1 360 361 362 363 364 890